Tirsit Asfaw, M.D.
NPI 1881891661 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · New York, NY
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Tirsit Asfaw, M.D. is a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider in New York, NY (NPI 1881891661).
Provider details
- NPI number
- 1881891661
- Entity type
- Individual
- Primary specialty
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- 244461 (NY)
Specialties & taxonomies
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary207VF0040XLicense 244461 (NY)
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
775 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 279 | $106 |
| Ultrasound Measurement of Bladder Capacity After Voiding51798 | 94 | $14 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 70 | $150 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 69 | $197 |
| Electronic Assessment of Bladder Emptying51741 | 33 | $9 |
| Non-Needle Measurement and Recording of Electrical Activity of Muscles at Bladder and Bowel Openings51784 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 79 | 40 |
| Mirabegronbrand: Myrbetriq | 46 | 15 |
| Vibegronbrand: Gemtesa | 28 | 13 |
| Estradiolbrand: Estring | 19 | — |
| Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim | 14 | 11 |
| Methenamine Hippurate | 13 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$105 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-06-27
- Last updated
- 2019-10-09
Frequently asked questions
- What is Tirsit Asfaw's NPI number?
- Tirsit Asfaw's National Provider Identifier (NPI) is 1881891661, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Tirsit Asfaw's specialty?
- Tirsit Asfaw is listed in the NPPES registry with a primary specialty of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician (Allopathic & Osteopathic Physicians).
- Where is Tirsit Asfaw located?
- Tirsit Asfaw's practice location on file with NPPES is 525 E 68th St # J130, New York, NY 10065-4870.
- What is Tirsit Asfaw's phone number?
- The practice phone number listed in the NPPES registry for Tirsit Asfaw is (212) 746-3376.
- Does Tirsit Asfaw accept Medicare?
- Tirsit Asfaw is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Tirsit Asfaw's NPI active?
- Yes — Tirsit Asfaw's NPI (1881891661) is active in the NPPES registry as of the last update on 2019-10-09.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.